Erratum: Antibody specification beyond the target: claiming a later-generation therapeutic antibody by its target epitope

Nat. Biotechnol. 30, 615–618 (2012); doi:10.1038/nbt.2291; published online 9 July 2012; corrected after print 7 December 2012

In the version of this article initially published, in Table 1 “Patents claiming anti-TNFα antibodies,” patent US 7012135 should have been assigned to UCB Pharma and not UC Berkeley. The error has been corrected in the PDF and HTML versions of this article.

Additional information

The online version of the original article can be found at 10.1038/nbt.2291

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sandercock, C., Storz, U. Erratum: Antibody specification beyond the target: claiming a later-generation therapeutic antibody by its target epitope. Nat Biotechnol 30, 1249 (2012). https://doi.org/10.1038/nbt1212-1249c

Download citation